2021 American Transplant Congress
Organ Decline Rate and Outcomes of Shared Kidneys from OneLegacy OPO Donation Service Area in Los Angeles
1UCLA David Geffen School of Medicine, Los Angeles, CA, 2OneLegacy, Los Angeles, CA
*Purpose: Background: 20% recovered kidneys are discarded in the US. Southern California has a high number of End-Stage Kidney Disease patients and the waitlist time…2021 American Transplant Congress
Comparison of Kidney Transplantation Outcomes Between Donors After Controlled Circulatory Death and Brain Death Donors in Catalonia, Spain
*Purpose: The number of kidney transplants (KT) from controlled cardiac death donors (cDCD) has exponentially increased in Spain during the last years. Results from cDCD…2021 American Transplant Congress
A Kidney Waitlist Outcomes Timeline to Visualize Candidate Offers and Outcomes
*Purpose: While transplant centers closely monitor posttransplant outcomes for each transplant recipient, centers currently lack data to monitor waitlist outcomes of individual candidates. Candidates who…2021 American Transplant Congress
Attitudes of Obese Kidney Transplant Candidates Towards Bariatric Surgery
Surgery, University of Illinois Hospital & Health Sciences System, Chicago, IL
*Purpose: Obesity is an epidemic in the US and increasingly prevalent in kidney transplant candidates. Surgical weight-loss interventions are effective and reduce transplant-related complications. They…2021 American Transplant Congress
Dosing Weight of Rabbit Antithymocyte Globulin and Outcomes Among Kidney Transplant Patients Treated for Rejection
Pharmacy, Northwestern Memorial Hospital, Chicago, IL
*Purpose: Rabbit antithymocyte globulin (rATG) is FDA approved for kidney transplant induction therapy and treatment of T-cell mediated rejection (TCMR). While prior studies comparing dosing…2021 American Transplant Congress
Sodium Zirconium Cyclosilicate Use in Kidney Transplant Recipients
University of Wisconsin-Madison, Madison, WI
*Purpose: Hyperkalemia is a common problem experienced by kidney transplant recipients (KTR)s. New strategies to treat hyperkalemia are now available. KTRs often require medications that…2021 American Transplant Congress
Preemptive Second Kidney Transplant Outcomes by Induction Type in the United States
*Purpose: Failed kidney allograft is the fourth leading indication for kidney transplantation. A significant portion of second kidney transplant recipients undergo preemptive transplantation while on…2021 American Transplant Congress
Modeling of Alternative Weight-Based Dosing Strategies of LCP-Tacrolimus in De Novo Kidney Transplant Patients
*Purpose: LCP-tacrolimus (LCPT; Envarsus XR®) is a modified-release once-daily formulation approved for prophylaxis of organ rejection in de novo kidney transplant patients in combination with…2021 American Transplant Congress
Very Long-Term Patient and Kidney Allograft Outcomes in Kidney Transplant Recipients More Than 20 Years After Transplantation:
University Hospital Zurich, Zürich, Switzerland
*Purpose: Despite rapid medical advancements in the field of transplantation over the last decades, long-term kidney allograft survival only slowly improves. Especially little is known…2021 American Transplant Congress
Multimodal Analgesia Reduces Length of Stay in Living Kidney Donors
*Purpose: This study evaluated the outcomes between living kidney donors who received a multimodal analgesic regimen compared to a historical cohort that did not.*Methods: Hartford…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 139
- Next Page »